Market Closed -
Australian S.E.
07:22:57 29/04/2024 am IST
|
5-day change
|
1st Jan Change
|
0.013
AUD
|
+8.33%
|
|
-13.33%
|
-7.14%
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
30.75
|
37.58
|
26.27
|
23.52
|
10.68
|
5.64
|
Enterprise Value (EV)
1 |
27.54
|
40.69
|
25.05
|
24.05
|
13.5
|
9.812
|
P/E ratio
|
-7.28
x
|
-5.42
x
|
-3.29
x
|
-16.2
x
|
-3.17
x
|
-1.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.58
x
|
7.43
x
|
4.32
x
|
3.23
x
|
1.31
x
|
0.78
x
|
EV / Revenue
|
2.31
x
|
8.04
x
|
4.12
x
|
3.3
x
|
1.65
x
|
1.36
x
|
EV / EBITDA
|
-6.67
x
|
-9.13
x
|
-10.6
x
|
-9.29
x
|
-6.65
x
|
-5.04
x
|
EV / FCF
|
-5.3
x
|
-9.99
x
|
-6.83
x
|
-16.1
x
|
-9.18
x
|
-10.9
x
|
FCF Yield
|
-18.9%
|
-10%
|
-14.6%
|
-6.21%
|
-10.9%
|
-9.18%
|
Price to Book
|
4.39
x
|
98.2
x
|
4.84
x
|
5.63
x
|
6.78
x
|
-5.74
x
|
Nbr of stocks (in thousands)
|
3,46,229
|
3,45,444
|
6,34,457
|
6,40,197
|
6,45,257
|
6,51,390
|
Reference price
2 |
0.0888
|
0.1088
|
0.0414
|
0.0367
|
0.0166
|
0.008658
|
Announcement Date
|
31/08/18
|
30/09/19
|
27/08/20
|
26/08/21
|
25/08/22
|
24/08/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
11.91
|
5.059
|
6.079
|
7.276
|
8.175
|
7.211
|
EBITDA
1 |
-4.13
|
-4.455
|
-2.365
|
-2.589
|
-2.029
|
-1.945
|
EBIT
1 |
-4.45
|
-4.803
|
-2.712
|
-2.735
|
-2.248
|
-2.198
|
Operating Margin
|
-37.36%
|
-94.94%
|
-44.62%
|
-37.59%
|
-27.5%
|
-30.48%
|
Earnings before Tax (EBT)
1 |
-3.961
|
-6.94
|
-6.125
|
-1.445
|
-3.36
|
-2.951
|
Net income
1 |
-3.961
|
-6.94
|
-6.125
|
-1.445
|
-3.36
|
-2.951
|
Net margin
|
-33.25%
|
-137.17%
|
-100.77%
|
-19.86%
|
-41.1%
|
-40.93%
|
EPS
2 |
-0.0122
|
-0.0201
|
-0.0126
|
-0.002267
|
-0.005226
|
-0.004561
|
Free Cash Flow
1 |
-5.199
|
-4.071
|
-3.669
|
-1.494
|
-1.471
|
-0.9008
|
FCF margin
|
-43.65%
|
-80.47%
|
-60.35%
|
-20.53%
|
-17.99%
|
-12.49%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
31/08/18
|
30/09/19
|
27/08/20
|
26/08/21
|
25/08/22
|
24/08/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
3.11
|
-
|
0.53
|
2.82
|
4.17
|
Net Cash position
1 |
3.22
|
-
|
1.21
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-0.699
x
|
-
|
-0.2037
x
|
-1.391
x
|
-2.145
x
|
Free Cash Flow
1 |
-5.2
|
-4.07
|
-3.67
|
-1.49
|
-1.47
|
-0.9
|
ROE (net income / shareholders' equity)
|
-111%
|
-188%
|
-211%
|
-30.1%
|
-117%
|
-996%
|
ROA (Net income/ Total Assets)
|
-24.3%
|
-24%
|
-16%
|
-15.4%
|
-16.6%
|
-23.3%
|
Assets
1 |
16.3
|
28.94
|
38.35
|
9.364
|
20.21
|
12.68
|
Book Value Per Share
2 |
0.0200
|
0
|
0.0100
|
0.0100
|
0
|
-0
|
Cash Flow per Share
2 |
0.0300
|
0.0100
|
0.0100
|
0
|
0
|
0
|
Capex
1 |
0.04
|
0.09
|
0.1
|
0.11
|
0.05
|
0.02
|
Capex / Sales
|
0.35%
|
1.79%
|
1.68%
|
1.55%
|
0.64%
|
0.26%
|
Announcement Date
|
31/08/18
|
30/09/19
|
27/08/20
|
26/08/21
|
25/08/22
|
24/08/23
|
|
1st Jan change
|
Capi.
|
---|
| -7.14% | 5.17M | | +11.78% | 63.22B | | -3.51% | 46.34B | | +13.09% | 39.97B | | +17.83% | 25.46B | | +8.37% | 18.68B | | +0.95% | 17.24B | | -21.73% | 15.81B | | +0.36% | 14.9B | | -13.38% | 13.74B |
Other Specialty Chemicals
|